Developing World Access To Medication: “Access to life-saving, essential medicines must be improved,” Josh Ruxin, founder and director of the Access Project and director of Rwanda Works,Â writes in a Forbes’ “Science Business” blog. After looking at the debate over whether the free market can help improve access and examining programs,…
Private Sector Involvement
Also In Global Health News: Canada’s Maternal Health Initiative; Mobile Giving; Interview With UNICEF Chief; Burning Biofuels And Anemia; ARVs In India
Sub-Saharan Africa To Receive Boost FromÂ Maternal, Child Health Initiative Canada will announce Monday “the 10 countries that will get help from the government’s $1.1-billion maternal and child health initiative,” 80 percentÂ of which is slated for sub-Saharan Africa, the Postmedia News/Vancouver Sun reports. The majority of the money will go to…
Al Jazeera Examines International Trade Agreement Negotiations, Access To Generic Medicines In Low-Income Countries
Al Jazeera examines what the outcomes of two international trade agreement negotiations â€“ one regarding free trade between the EU and India and the other over anti-counterfeiting measures â€“ could mean for patients living with HIV/AIDS in low-income countries.
African Private Sector Can Play Key Role In Improving Health Outcomes In Africa “The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses,” First Lady of Rwanda Jeannette Kagame and CEO of…
The U.S. is falling short on its goal of improving conditions for the 2.6 billion people worldwide without access to clean water and sanitation despite the fact the Water for the Poor Act became law in 2005, according to a report (.pdf) released Thursday by the Natural Resources Defense Council (NRDC), WaterAid, CARE and 11 other organization, Food Safety News reports (11/19).
In recent years, pharmaceutical companies in the Asia-Pacific region have ramped up their clinical trial activity, patent challenges of brand name drugs and their development of new products, according to report released Tuesday by CMR International, a Thomson Reuters business, Reuters reports.
Ahead of World AIDS Day, the International Federation of the Red Cross on Friday released a report (.pdf) calling for governments around the world to do more to help stop the spread of HIV/AIDS among populations of injecting drug users (IDUs), the Associated Press reports (Heilprin, 11/25).
GAVI Says Pentavalent Vaccine Price To Fall, But $3.7B Still Needed To Vaccinate Children In Developing Countries
The average price of a vaccine that protects children against five diseases is expected to “drop to $2.58 next year compared to the current average price of $2.97,” the GAVI Alliance said Friday, Reuters reports. The group credits the expected price decline, which “represents a decrease of 30 percent over the last seven years,” in part to an “increased demand for the pentavalent, or five-in-one vaccine,” according to the news service (Kelland, 11/26).
Nature News reports on an immunization campaign kicking off in Africa in December that will offer protection to some areas of Africa’s meningitis belt. “Millions will receive a new vaccine, MenAfriVac, that promises protection against the meningococcal bacterium Neisseria meningitides,” the news service writes, noting the effort “is the culmination of ten years’ work by an international consortium to develop a vaccine at a price low enough for massive use in Africa: just US$0.40 a dose.”
“The world’s biggest rich and emerging powers escalated a war of words over trade and currencies Thursday, as leaders opened a G20 summit [in Seoul, South Korea] struggling to iron out distortions that threaten global growth,” Agence France-Presse reports in an article examining some of the major disputes (Chan-Kyong, 11/11).